Jonathan Aschoff

JONATHAN ASCHOFF, PhD, joined the healthcare team of Friedman, Billings,
Ramsey & Co., Inc. (FBR) as a Senior Research Analyst in March 2001.
Prior to joining the firm, Dr. Aschoff was a Senior Research Analyst at
Dain Rauscher Wessels covering genomics and had worked as a more
generalized biotech analyst at Sturza’s Institutional Research, where he
covered antimicrobial and oncology therapeutics, therapeutic antibodies,
gene therapy and genomics. Dr. Aschoff received his PhD in Microbiology
and Molecular Biology and his BS in Biology from Tufts University.